Tivic Health Names Mindgruve Leading Digital Marketing Agency | Business
SAN FRANCISCO – (BUSINESS WIRE) – Dec. 20 2021–
Tivic Health Systems, Inc. (Nasdaq: TIVC), an emerging growth company focused on non-invasive bioelectronic medicine, names Mindgruve, a modern marketing agency, as the go-to digital marketing agency. Mindgruve will work with Tivic Health to develop an integrated marketing and branding strategy that supports marketing and sales efforts in the United States
Tivic Health develops non-pharmaceutical bioelectronic products to treat disease and help individuals improve their quality of life. The company’s first FDA-approved product, ClearUP® Sinus Pain Relief, is a patented wearable device that uses ultra-low level electronic waves to relieve sinus pain and congestion, common symptoms of sinus inflammation. and nose.
“We selected Mindgruve based on their extensive experience helping consumer and healthcare brands build successful businesses,” said Jennifer Ernst, CEO of Tivic Health. “They will focus on optimizing and upgrading our e-commerce platforms, digital and social marketing and overall brand development, further raising awareness of bioelectronic options for disease treatment and improvement. of health. “
“We are excited to be working with the team at Tivic Health to create a compelling brand in bioelectronic medicine, with a lead product in the large and growing sinus care market,” said Chad Robley, CEO and Founder of Mindgruve.
Mindgruve is a global, independent marketing agency of strategists, creatives, media experts, data scientists and engineers from around the world driven by a common goal: to create groundbreaking work that helps brands drive growth. of their business. For more information visit https://mindgruve.com/
About Tivic Health Systems, Inc.
Tivic Health Systems, Inc. is a commercial-stage health technology company advancing bioelectronic medicine to provide non-invasive solutions that treat disease, increase wellness, and improve life. The company develops non-invasive products that provide consumers with choice in the treatment of inflammation and related conditions. For more information visit https://tivichealth.com @TivicHealth
This press release may contain “forward-looking statements” which are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate”, “believe”, “contemplate”, “might”, “estimate”, “expect”, “have l ‘intention’, ‘seek’, ‘may’, ‘could’, ‘plan’, ‘potential’, ‘predict’, ‘plan’, ‘target’, ‘aim’, ‘should’, ‘will’ ‘would’ or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc. current expectations and are subject to inherent uncertainties, risks and assumptions which are difficult to predict. In addition, certain forward-looking statements are based on assumptions about future events which may not prove to be correct. Additional information regarding Tivic Health and its business, including a discussion of factors that could significantly affect the company’s operating results, is contained in the company’s registration statement on Form S-1 ( and its amendments) under the heading “Risk Factors”, as well as the Company’s subsequent filings with the Securities and Exchange Commission. The forward-looking statements contained in this announcement are made as of this date, and Tivic Health Systems, Inc. assumes no obligation to update such information, except as required by applicable law.
View source version on businesswire.com:https://www.businesswire.com/news/home/20211220005487/en/
CONTACT: Media contact:
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: MARKETING COMMUNICATIONS MEDICAL DEVICES HEALTH GENERAL HEALTH BIOTECHNOLOGY
SOURCE: Tivic Health Systems, Inc.
Copyright Business Wire 2021.
PUB: 12/20/2021 9:20 a.m. / DISC: 12/20/2021 9:22 a.m.
Copyright Business Wire 2021.